Artiva Biotherapeutics Inc. Common Stock (ARTV)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
6.54
0.01 (0.15%)
Jan 21, 2025, 9:37 AM - Market open
0.15% (1D)
Bid | 6.5 |
Market Cap | 158.85M |
Revenue (ttm) | 3.34M |
Net Income (ttm) | -73.20M |
EPS (ttm) | -2.48 |
PE Ratio (ttm) | -2.64 |
Forward PE | -3.79 |
Analyst | Buy |
Ask | 6.71 |
Volume | 5,396 |
Avg. Volume (20D) | 60,533 |
Open | 6.86 |
Previous Close | 6.53 |
Day's Range | 6.54 - 6.86 |
52-Week Range | 6.50 - 17.31 |
Beta | 0.00 |
About ARTV
A detailed description of the company is not yet available....
Analyst Forecast
According to 6 analyst ratings, the average rating for ARTV stock is "Buy." The 12-month stock price forecast is $21, which is an increase of 221.10% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
Why Price Moved
2 months ago
-10.48%
Artiva Biotherapeutics shares are trading lower af...
Unlock content with
Pro Subscription
News
6 months ago · seekingalpha.com
U.S. IPO Weekly Recap: Insurance And Healthcare Lead A 4 IPO WeekA handful of IPOs priced this past week, led by three sizable names. One large issuer joined both the pipeline and the calendar - Chile-based LATAM Airlines Group. Six IPOs are scheduled to list in th...